Targeting B7-H3 (CD276) in neuroblastoma: In vitro evaluation of Fc-optimized antibodies and immunocytokines

被引：2
|
作者：
Heubach, Florian
Schlegel, Patrick
Zekri, Latifa
Manz, Timo
Schleicher, Sabine
Rabsteyn, Armin
Jung, Gundram
Buehring, Hans-Joerg
Gillies, Stephen D.
Handgretinger, Rupert
Lang, Peter
机构：
[1] Childrens Univ Hosp, Tubingen, Germany
[2] Eberhard Karls Univ Tubingen, Tubingen, Germany
[3] German Canc Consortium DKTK, Tubingen, Germany
[4] German Canc Res Ctr, Tubingen, Germany
[5] Provenance Biopharmaceut, Carlisle, MA USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2019年 / 7卷 / 02期
关键词：
D O I：
10.1158/2326-6074.CRICIMTEATIAACR18-A131
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A131
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Immunocytokines and FC-optimized antibodies targeting B7-H3 (CD276) in neuroblastoma
    Heubach, Florian
    Schlegel, Patrick
    Zekri, Latifa
    Manz, Timo
    Schleicher, Sabine
    Rabsteyn, Armin
    Jung, Gundram
    Buehring, Hans-Joerg
    Gillies, Stephen D.
    Handgretinger, Rupert
    Lang, Peter
    BONE MARROW TRANSPLANTATION, 2019, 54 : 544 - 545
  • [2] Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody
    Stefanczyk, Sylwia A.
    Hagelstein, Ilona
    Lutz, Martina S.
    Mueller, Stefanie
    Holzmayer, Samuel J.
    Jarjour, Grace
    Zekri, Latifa
    Heitmann, Jonas S.
    Salih, Helmut R.
    Maerklin, Melanie
    BLOOD CANCER JOURNAL, 2024, 14 (01)
  • [3] B7-H3/CD276: An Emerging Cancer Immunotherapy
    Zhou, Wu-Tong
    Jin, Wei-Lin
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [4] Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy
    Picarda, Elodie
    Ohaegbulam, Kim C.
    Zang, Xingxing
    CLINICAL CANCER RESEARCH, 2016, 22 (14) : 3425 - 3431
  • [5] Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer
    Inamura, Kentaro
    Takazawa, Yutaka
    Inoue, Yosuke
    Yokouchi, Yusuke
    Kobayashi, Maki
    Saiura, Akio
    Shibutani, Tomoko
    Ishikawa, Yuichi
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (07)
  • [6] Clinicopathological and Prognostic Characteristics of CD276 (B7-H3) Expression in Adrenocortical Carcinoma
    Liang, Jiayu
    Liu, Zhihong
    Pei, Tianjiao
    Xiao, Yingming
    Zhou, Liang
    Tang, Yongquan
    Zhou, Chuan
    Wu, Kan
    Zhang, Fuxun
    Zhang, Fan
    Yin, Xiaoxue
    Chen, Ni
    Wei, Xin
    Lu, Yiping
    Zhu, Yuchun
    DISEASE MARKERS, 2020, 2020
  • [7] Tumor B7-H3 (CD276) expression and survival of patients with pancreatic cancer
    Inamura, Kentaro
    Yokouchi, Yusuke
    Kobayashi, Maki
    Inoue, Yosuke
    Saiura, Akio
    Takazawa, Yutaka
    Ishikawa, Yuichi
    CANCER RESEARCH, 2018, 78 (13)
  • [8] Preclinical Efficacy of CD276 (B7-H3) CAR T in Acute Myeloid Leukemia
    Lira, Isabel
    Kirkey, Danielle C.
    Nicolaidou, Marilena
    Muller, Henrike
    Barisa, Marta
    Blankenfeld, Melia
    Hawkins, Grace
    Mckay, Cyd
    Root, Christina
    Pardo, Laura
    Loken, Michael R.
    Hylkema, Tiffany
    Quintarelli, Concetta
    Locatelli, Franco
    Anderson, John
    Meshinchi, Soheil
    BLOOD, 2024, 144 : 4793 - 4793
  • [9] New frontiers in immune checkpoint B7-H3 (CD276) research and drug development
    Ayechew Adera Getu
    Abiye Tigabu
    Ming Zhou
    Jianrong Lu
    Øystein Fodstad
    Ming Tan
    Molecular Cancer, 22
  • [10] New frontiers in immune checkpoint B7-H3 (CD276) research and drug development
    Getu, Ayechew Adera
    Tigabu, Abiye
    Zhou, Ming
    Lu, Jianrong
    Fodstad, Oystein
    Tan, Ming
    MOLECULAR CANCER, 2023, 22 (01)
12345